Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.

Cancer treatment and research - 1 Jan 1997

Gagel R F

Abstract excerpt

The identification of ret protooncogene mutations in MEN-II and Hirschsprung disease has not only improved the clinical management of these genetic conditions but has also provided important information regarding mechanisms of transformation and neural crest development. An indication of how neural-crest cells migrate during embryonic life and the key processes involved in their differentiation now seems within...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Medullary
Share to Genetic Testing
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiple Endocrine Neoplasia Type 2b

Share to Mutation

Share to Pheochromocytoma

Share to Proto-Oncogenes

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 9204204
DOI: 10.1007/978-1-4615-6355-6_20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.PMID 9204204Read ↗

Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitorsSemantic proximity Read ↗

Hereditary medullary thyroid carcinoma: how molecular genetics made multiple endocrine neoplasia type 2 a paediatric disease.Semantic proximity Read ↗

Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.Semantic proximity Read ↗

Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.Semantic proximity Read ↗

RET gene abnormalities and thyroid disease: who should be screened and when.Semantic proximity Read ↗

Molecular advances in medullary thyroid cancer diagnostics.Semantic proximity Read ↗

The Multiple Endocrine Neoplasia SyndromesSemantic proximity Read ↗

Multiple endocrine neoplasia type 2: 2007 update.Semantic proximity Read ↗

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.